Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease

Luthra, Gurinder; Pasricha, P. Jay
May 2002
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p92
Academic Journal
Comments on a study which discovered that olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis. Comparison of the effects of olsalazine and placebo on patients; Assessment of adverse events in patients; Effects of mesalamine on patients.


Related Articles

  • Continuing Medical Education Questions: Supplement 1, April 2011. DeVault, Kenneth R. // American Journal of Gastroenterology;Apr2011 Supplement, Vol. 106, pS26 

    A quiz concerning the treatment for inflammatory bowel disease (IBD) is presented.

  • Some of the best medicines are all in the mind. Motluk, Alison // New Scientist;8/18/2001, Vol. 171 Issue 2304, p19 

    Reports on the positive effect of placebos on health. Details of a study conducted on patients with Parkinson's disease using either a placebo or apomorphine drug.

  • Isotretinoin and Risk of Inflammatory Bowel Disease. Dai, Cong; Jiang, Min; Sun, Ming-Jun // American Journal of Gastroenterology;Sep2014, Vol. 109 Issue 9, p1493 

    A letter to the editor is presented in response to the article "Isotretinoin and risk of inflammatory bowel disease: A French Nationwide Study" by Racine A and colleagues in the 2014 issue of the journal.

  • Response to Dai et al. Racine, Antoine; Boutron-Ruault, Marie-Christine; Carbonnel, Franck // American Journal of Gastroenterology;Sep2014, Vol. 109 Issue 9, p1494 

    A response from the author of the article "Isotretinoin and risk of inflammatory bowel disease: A French nationwide study" in the 2014 issue of the journal is presented.

  • Is there a place for placebo controlled trials of antiepileptic drugs? Shorvon, S.D.; Espir, M.L.E.; Steiner, T.J.; Dellaportas, C.I.; Rose, F. Clifford // British Medical Journal (Clinical Research Edition);11/9/1985, Vol. 291 Issue 6505, p1328 

    Examines the possibility of a placebo controlled trials on antiepileptic drugs in Great Britain. Uncertainty on the role of anticonvulsant drugs on epileptics; Impact of epileptic seizures on the psychology and social behavior of epileptics; Natural history of epilepsy.

  • Relief of Idiopathic Generalized Pruritus in Dialysis Patients Treated with Activated Oral Charcoal. Pederson, James A.; Matter, Billy J.; Czerwinski, Anthony W.; Llach, Francisco // Annals of Internal Medicine;Sep80, Vol. 93 Issue 3, p446 

    Presents information on a study which compared the effect of oral charcoal on idiopathic generalized pruritus in stable patients undergoing maintenance hemodialysis to that of placebo dextrose. Results of skin tests; Effect of charcoal and placebo treatment upon the skin lesions; Discussion on...

  • Hypnotic self administration: forced-choice versus single-choice. Roehrs, T.; Pedrosi, Bonita; Rosenthal, Leon; Zorick, Frank; Roth, Thomas // Psychopharmacology;1997, Vol. 133 Issue 2, p121 

    Abstract Twenty-four men and women with insomnia, age 21-50 years, self administered hypnotics under a single-choice with placebo, single-choice with triazolam (0.25 mg), or forced-choice of placebo versus triazolam (0.25mg) paradigm. Subjects received 4- sampling nights of placebo or triazolam...

  • Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year. Jolley, A.G.; Hirsch, S.R.; McRink, A.; Manchanda, R. // BMJ: British Medical Journal (International Edition);4/15/89, Vol. 298 Issue 6679, p985 

    Evaluates the trial of intermittent neuroleptic prophylaxis for schizophrenic outpatients in Great Britain. Approach to prophylaxis of schizophrenic relapse; Outline of the treatment strategy; Administration of placebo injections.

  • How to produce not only powerful but, more importantly, reliable placebo healing and analgesia. Wickramasekera, Ian // Advances in Mind-Body Medicine;Summer2000, Vol. 16 Issue 3, p211 

    Presents a conditioned response model replete testable predictions. Proposal of the Pavlovian learning mechanism on the placebo effect; Association of unconditioned stimuli for healing with more powerful placebo effects; Alteration of the body physicochemically and behaviorally.

  • Controlled trial of speech therapy versus oxprenolol for stammering. Rustin, Lena; Kuhr, A.; Cook, P.J.; James, I.M. // British Medical Journal (Clinical Research Edition);8/22/1981, Vol. 283 Issue 6290, p517 

    Examines the placebo and oxprenolol for speech therapy in Great Britain. Decrease in pulse rate and systolic blood pressure with oxprenolol; Improvement in extensive speech therapy; Effectiveness of the treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics